Carter F. Thurman practices in the Firm’s Complex Litigation, Pharmaceutical Products, and Toxic Torts & Products Liability groups. His experience includes prosecuting commercial contract claims against a large company that formerly co-owned and operated a chemical plant under both breach of contract and contractual indemnification causes of action with hundreds of millions of dollars at stake. Read More >
Hollingsworth LLP outwits well-funded plaintiffs' attorney group by prevailing in early trials (including plaintiffs' trial picks) in consolidated litigation for client Novartis Pharmaceuticals Corporation.
11th Circuit affirmance in Rider v. Sandoz Pharmaceuticals completes circuit court Daubert sweep in Parlodel® litigation.
Avondale Mills, Inc. v. Norfolk Southern Corp., Civ. No. 1:05-2817-MBS (D.S.C. 2008)
New Mexico v. Gen. Electric Co., 467 F.3d 1223 (10th Cir. 2006)
Allgood v. General Motors Corp., No. 1:02-cv-1077-DFH-TAB (S.D. Ind. Sept. 18, 2006)
Verdicts & Opinions
Johnson v. Novartis Pharms. Corp., et al., No. 5:19-cv-01087-OLG (May 7, 2020).
Stirling v. Novartis Pharms. Corp., et al., No. CV01-18-4880 (Sept. 25, 2019)
Brad Lafferty, et al. v. The Sherwin-Williams Company, et al., Case No. 1:17-cv-06321, at *8 (D.N.J. Aug. 21, 2018)
McWilliams v. Novartis AG, et al., No. 2:17-cv-14302-RLR (July 31, 2018)
Martinez v. American International Industries, et al., No. MID-L-1120-17AS (June 15, 2018)
News & Publications
The Fund will provide cash and in-kind donations for immediate response and recovery efforts related to the pandemic. Details of this effort, information on how to apply, and links to related resources are available in the April 3rd press release.
Samarth Barot co-authors article in The Construction Lawyer (Spring 2020 edition)
Print as PDF.